Diabetes in Hospital: A Practical Approach for Healthcare Professionals

Diabetes in Hospital: A Practical Approach for Healthcare Professionals

Volumn , Issue , 2009, Pages 1-212

  Holt, Paula ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955818133     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470749746     Document Type: Book

References (249)

1. ABPI/Diabetes UK (2006) Ask about medicines. Diabetes Medicines Information Survey. http://www.abpi.org.uk/%2Fpublications%2Fpdfs%2Fdiabetes_jigsaw.pdf (accessed 15 July 2008).
2. Ahmed, B. (2004) Pharmacology of insulin. Diabetes and Vascular Disease, 4, 10-13.
3. Akerblom, H.K., Vaarala, O., Hyoty, H., Ilanen, J. and Knip, M. (2002) Environmental factors in the etiology of type 1 diabetes. American Journal of Medical Genetics, 115, 18-29.
4. Albarran, N.B., Ballesteros, M.N., Morales, G.G. and Ortega, M.I. (2006) Dietary behaviour and type 2 diabetes care. Patient Education and Counselling, 61, 191-9.
5. Alberti, K.G.M.M. and Thomas, D.J.B. (1979) The management of diabetes during surgery. British Journal of Anaesthesia, 51, 693-710.
6. Alberti, K.G.M.M., Simmet, P. and Shaw, J. (2005) The metabolic syndrome-a new worldwide definition. The Lancet, 366, 1059-62.
7. American Diabetes Association. (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 26, S5-20.
8. American Diabetes Association. (2004a) Hypertension management in adults with diabetes. Diabetes Care, 27, S65-7.
9. American Diabetes Association (2004b) Nephropathy in diabetes (position statement). Diabetes Care, 27 (Suppl.1), S79-83.
10. American Diabetes Association. (2005a) Tests of glycaemia in diabetes. Diabetes Care, 27, S91-3.
11. American Diabetes Association. (2005b) Standards of medical care in diabetes. Diabetes Care, 38, S4-36.
12. American Diabetes Association. (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care, 29, S43-8.
13. Angulo, P. (2002) Non-alcoholic fatty liver disease. New England Journal of Medicine, 346, 1221-31.
14. Angulo, P., Keach, J.C., Batts, K.P. and Lindor, K.D. (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Heptology, 30, 1356-62.
15. Antonelli, A., Ferrari, S.M., Ferri, C., et al. (2005) Hepatitis C virus infection. Diabetes Care, 28, 2548-50.
16. Arner, P. (2005) Insulin resistance in type 2 diabetes-role of the adipokines. Current Molecular Medicine, 5, 333-9.
17. Aschner, P., Kipnes, M., Lunceford, J., Mickel, C., Davies, M. and Williams-Hermann, D. (2006) Sitagliptin monotherapy improved glycaemic control in the fasting and postprandial states and beta-cell function after 24 weeks in patients with type 2 diabetes (T2DM). Diabetes, 55, (Suppl. 1), 462, (abstract 1995-PO).
18. Astrup, A. (2003) Is there any conclusive evidence that exercise alone reduces glucose intolerance? The British Journal of Diabetes and Vascular Disease, 3, (Suppl. 1), S18-23.
19. Bäckman, L.A. (2004) Post-transplant diabetes mellitus: the last 10 years with tacrolimus. Nephrology Dialysis Transplantation, 19, (Suppl. 6), vi13-vi16.
20. Bailey, C.J. and Feher, M.D. (2004) Therapies for Diabetes. Sherborne Gibbs, Birmingham.
21. Bazzano, L.A., Li, T.Y., Joshipura, K.J. and Hu, F.B. (2008) Intake of fruit, vegetables and fruit juices and risk of diabetes in women. Diabetes Care, 31, 1311-17.
22. Belch, J., Stansby, G., Shearman, C., et al. (2007) Peripheral arterial disease-a cardiovascular time bomb. The British Journal of Diabetes and Vascular Disease, 7, 236-9.
23. Bhattacharyya, A., Christodoulides, C., Kaushal, K., New, J.P. and Young, R.J. (2000) Inpatient management of diabetes mellitus and patient satisfaction. Diabetic Medicine, 19, 412-16.
24. Bleyer, A.J., Sedor, J.R., Freedman, B.I., et al. (2008) Risk factors for the development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease. American Journal of Kidney Disease, 51, 29-37.
25. Bloomgarden, Z.T. (2007) Diabetic neuropathy. Diabetes Care, 30, 1027-32.
26. Bonifacio, E., Hummelm M., Walter, M., Schmid, S. and Ziegler, A.G. (2004) IDDM and multiple family history of Type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care, 27, 2695-700.
27. Bosi, E., Conti, M., Vermigli, C., et al. (2005) Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia, 48, 817-23.
28. Boulton, A.J.M., Gries, F.A. and Jervell, J.A. (1998) Guidelines for the diagnosis and outpatient management diabetic peripheral neuropathy. Diabetic Medicine, 15, 508-14.
29. Boulton, A.J.M., Kirsner, R.S. and Viliekyte, L. (2004) Neuropathic diabetic foot ulcers. New England Journal of Medicine, 351, 48-55.
30. Boulton, A.J.M., Vinik, A.I., Arezzo, J.C., et al. (2005) Diabetic neuropathies. Diabetes Care, 28, 956-62.
31. British National Formulary (2008) http://www.bnf.org/bnf/(accessed 29 September 2008).
32. British Society for Haematology (2000) Genetic haemochromatosis. http://www. bcshguidelines.com (accessed 2 May 2008).
33. Brook, C.G. and Marshall, N.J. (2001) Essential Endocrinology. Blackwell Science, Oxford.
34. Broom, I. (2006) Thinking about abdominal obesity and cardiovascular risk. The British Journal of Diabetes and Vascular Disease, 6, 58-61.
35. Bugianesi, E., Gentilcore, E., Manini, R., et al. (2005) A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. American Journal of Gastroenterology, 100, 1082-90.
36. Campbell, I.W. and Day, C. (2007) Sitagliptin-enhancing incretin action. The British Journal of Diabetes and Vascular Disease, 7, 134-9.
37. Carr, D.B., Utzschneider, K.M., Hull, R.L., et al. (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes, 53, 2087-94.
38. Carral, F., Olveira, G., Sala, J., Garcia, L., Sillero, A. and Aguilar, M. (2002) Care resource utilization and direct costs incurred by people with diabetes in a Spanish hospital. Diabetes Research and Clinical Practice, 56, 27-34.
39. Carral, F., Aguilar, M., Oliveira, G., Mangas, A., Domenech, I. and Torres, I. (2003) Increased hospital expenditures in diabetic patients hospitalized for cardiovascular diseases. Journal of Diabetes and its Complications, 17, 331-6.
40. Centre for Drug Evaluation and Research (1999). Approval package: Avandia (rosiglitazone maleate) tablets. Company: Smith Kline Beecham Pharmaceuticals. Application no. 21-071. Approval date: 5/25/1999. http://www.fda.gov/cder/foi/nda/99/21071_ Avandia.htm (accessed 21 July 2007).
41. Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M.D. and Hall, S.D. (2004) Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology, 126, 1287-92.
42. Chan, W. (2003) Food and Diet Counter. Hamlyn, London.
43. Clayton, M. and Holt, P. (2006) Hereditary haemochromatosis and diabetes-implications for practice. Gastrointestinal Nursing, 4, 22-6.
44. Clements, G.B., Galbraith, D.N. and Taylor, K.W. (1995) Coxsackie B virus infection and onset of childhood diabetes. The Lancet, 346, 221-3.
45. Colhoun, H.M., Betteridge, D.J., Durrington, P.N., et al. (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. The Lancet, 364, 685-96.
46. Colombani, P.C. (2004) Glycaemic index and load-dynamic dietary guidelines in the context of diseases. Physiology and Behavior, 83, 603-10.
47. Confidential Enquiry into Maternal and Child Health (2007) http://www.cemach.org.uk (accessed 25 July 2007).
48. Conway, B., Fried, L. and Orchard, T. (2008) Haemoglobin and overt nephropathy complications in type 1 diabetes. Annals of Epidemiology, 18, 147-55.
49. Cooper, M.E. (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. The Lancet, 352, 213-19.
50. Cowburn, C. (2004) Preventing type 2 diabetes by preventing obesity: what do population-based approaches offer? Obesity in Practice, 6, 13-15.
51. Cummings, J., Mineo, K., Levy, R. and Josephson, R.A. (1999) A review of the DIGAMI study: intensive insulin therapy during and after myocardial infarctions in diabetic patients. Diabetes Spectrum, 12, 84-8.
52. DAFNE Collaborative (2003) DAFNE Collaborative: the roll-out experience. http://www. dafne.uk.com/downloads.DoH%20report.pdf (accessed 14 July 2008).
53. DAFNE Study Group. (2002) Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. British Medical Journal, 325, 746.
54. Davies, M.J., Heller, S., Skinner, T.C., et al. (2008) Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. British Medical Journal, 336, 491-5.
55. Deakin, T.A., Cade, J.E., Williams, R. and Greenwood, D.C. (2006) Structured patient education: the Diabetes X-PERT Programme makes a difference. Diabetic Medicine, 23, 944-54.
56. DeFronzo, R.A., Ratner, R.E., Han, J., Kim, D.D., Fineman, M.S. and Baron, A.D. (2005) Effects of exenatide (exendin-4) on glycaemic control and weigh over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care, 28, 1092-2000.
57. Department of Health (2001) National Service Framework for Diabetes: Standards. Department of Health, London.
58. Department of Health (2003) National Service Framework for Diabetes: Delivery Strategy. Department of Health, London.
59. Department of Health (2006a) Forecasting obesity to 2010. http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsStatistics/DH_4138630 (accessed 21 January 2008).
60. Department of Health (2006b) http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_4139673 (accessed 29 April 2008).
61. Department of Health (2007) Obesity general information. http://www.dh.gov.uk/en/Policyandguidance/ Healthandsocialcaretopics/Obesity (accessed 22 January 2008).
62. Deville-Almond, J. (2003) An innovative approach to weight management. Obesity in Practice, 5, 6-8.
63. Diabetes Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 326, 683-9.
64. Diabetes Control and Complications Trial Research Group. (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney International, 47, 1703-20.
65. Diabetes Control and Complications Trial Research Group. (1997) Hypoglycaemia in the Diabetes Control and Complications Trial. Diabetes, 46, 271-86.
66. Diabetes UK (2001) Guidelines for the management of diabetic ketoacidosis in children and adolescents. http://www.diabetes.org.uk (accessed 22 July 2008).
67. Diabetes UK (2005) Type 2 diabetes and obesity: a heavy burden. Avaiable from: http://www.diabetes.org.uk/Site_Search/?p=1andpr=114andandt1=obesityandt2=andt3= andt4=andd1=andd2=andd3=andd4=andd5=andd6=andchk=00000100000 (accessed 23 November 2007).
68. Diabetes UK (2006a) Reports and statistics. http://www.diabetes.org.uk/Professionals/ Information_resources/Reports/Diabetes_prevalence_2006/(accessed 21 June 2007).
69. Diabetes UK (2006b) Analogue insulin. http://www.diabetes.org/Guide-to-diabetes/ Guide_to_Diabetes_Archived_pages/Anal (accessed 6 July 2007).
70. Diabetes UK (2008) Year of care. http://www.diabetes.org.uk/Professionals/Year-of-Care/ (accessed 28 October 2008)
71. DIAMOND Project Group. (2006) Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine, 23, 857-66.
72. Dinneen, S.F. (2008) Structured education for people with type 2 diabetes. British Medical Journal, 336, 459-60.
73. Disability Discrimination Act (1995). http://www.opsi.gov.uk/acts/acts1995/1995050.htm (accessed 25 July 2007).
74. Dixon, J.B., Bhathal, P.S., Hughes, N.R. and O'Brien, P.E. (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology, 39, 1647-54.
75. Donnelly, R. (2005) Managing cardiovascular risk in patients with diabetes. The British Journal of Diabetes and Vascular Disease, 5, 325-9.
76. Drucker, D.J. (2007) The role of gut hormones in glucose homeostasis. Journal of Clinical Investigation, 117, 24-32.
77. Drucker, D.J. and Nauck, M.A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet, 368, 1696-705.
78. Edmonds, M.E. and Foster, A.V.M. (2000) Managing the Diabetic Foot. Blackwell Science, Oxford.
79. Elliott, R.B., Reddy, S.N., Bibby, N.J. and Kida, K. (1988) Dietary prevention of diabetes in the non-obese diabetic mouse. Diabetologia, 31, 62-4.
80. Erdmann, E. (2007) Statin plus thiazolidinedione use in patients with diabetes at high cardiovascular risk. The British Journal of Diabetes and Vascular Disease, 7, 211-16.
81. EURODIAB Substudy 2 Study Group. (1999) Vitamin D supplement in early childhood and risk for Type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 42, 51-4.
82. European Association for the Study of the Liver. (2000a) EASL International Consensus Conference of Haemochromatosis-Part III. Jury document. Journal of Hepatology, 33, 496-504.
83. European Association for the Study of the Liver. (2000b) EASL International Consensus Conference of Haemochromatosis-Part II. Expert document. Journal of Hepatology, 33, 487-96.
84. Evans, J.J., Youngren, J.F. and Goldfine, I.D. (2004) Effective treatments for insulin resistance: trim the fat and douse the fire. Trends in Endocrinology and Metabolism, 15, 425-31.
85. Faideau, B., Larger, E., Lepault, F., Carel, J.C. and Boitard, C. (2005) Role of β-cells in Type 1 diabetes pathogenesis. Diabetes, 54, S87-96.
86. Fanelli, C., Pampanelli, S., Epifano, L., et al. (1994) Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia, 37, 797-807.
87. Feder, J.N., Gnirke, A., Thomas, W., et al. (1996) A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics, 13, 399-408.
88. Fioretto, P., Bruseghin, M., Barzon, I., Arboit, M. and Dalla Vestra, M. (2007) Diabetic nephropathy: an update on renal structure. International Congress Series, 1303, 51-9.
89. Foresight (2007) Tackling obesities: future choices. http://www.foresight.gov.ukproject (accessed 21 January 2008).
90. Foreyt, J.P. and Poston, C. (1999) The challenge of diet, exercise and lifestyle modification in the management of the obese diabetic patient. International Journal of Obesity, 7, S5-11.
91. Foster H (2004) Easy GI Diet. Hamlyn, London.
92. Fraser, D.J. and Phillips, A.O. (2007) Diabetic nephropathy. Medicine, 35, 503-6.
93. French, G. (2000) Clinical management of diabetes mellitus during anaesthesia and surgery. Practical Procedures, 11, 1-3.
94. Galbraith, A., Bullock, S., Manias, E., Hunt, B. and Richards A (1999) Fundamentals of Pharmacology. Addison Wesley Longman, Harlow.
95. Gallop, R. and Renton, H. (2005) The GI Guide. Virgin Books, London.
96. Hales, C.N. and Barker, D.J.P. (2001) The thrifty phenotype hypothesis. British Medical Bulletin, 60, 5-20.
97. Gillespie, G.L. and Campbell, M. (2002) Diabetic ketoacidosis: rapid identification, treatment, and education can improve survival rates. American Journal of Nursing, 102, 13-16.
98. Gillespie, K.M., Bain, S.C., Barnett, A.H., Bingley, P.J., Christie, M.R. and Gill, G.V. (2004) The rising incidence of childhood type 1 diabetes and reduction contribution of high-risk HLA haplotypes. The Lancet, 364, 1699-700.
99. Goldman, L. (1995) Cardiac risk in non cardiac surgery: an update. Anaesthesia and Analgesia, 80, 810-20.
100. Goldrick, B.A. (2003) Surgical-site infections. American Journal of Nursing, 103, 64A.
101. Greenstein, A., Tavaloli, M., Mojaddidi, M., Al-Sunni, A., Matfin, G. and Malik, R.A. (2007) Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development. The British Journal of Diabetes and Vascular Disease, 7, 166-71.
102. Gross, E.R., LaDisa, J.F., Weihrauch, D., et al. (2003) Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycaemia. American Journal of Physiology, 284, H1552-9.
103. Gross, J.L., Canani, L.H., de Azevedo, M.J., Caramori, M.L., Silveiro, S.P. and Zelmanovitz, T. (2005) Diabetic nephropathy: diagnosis, prevention and treatment. Diabetes Care, 28, 164-76.
104. Grundy, S.M., Cleeman, J.I., Donato, K.A., et al. (2005) Diagnosis and management of the metabolic syndrome. Circulation, 112, 2735-52.
105. Guenaga, K., Atallah, A.N., Castro, A.A., Matos, D.D.M. and Wille-Jørgensen, P. (2007) Mechanical bowel preparation for elective colorectal surgery. Cochrane Database of Systematic Reviews, Issue 4. The Cochrane Collaboration, John Wiley, London.
106. Guidorizzi de Siqueira, A.C., Cotrim, H.P., Rocha, R., et al. (2005) Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. European Journal of Gastroenterology and Hepatology, 17, 837-41.
107. Haag, B.L. (2000) Presurgical management of the patient with diabetes. In: Medical Management of Diabetes (eds J.L. Leahy, N.G. Clark and W.T. Cefalu), pp. 631-9. Marcel Dekker, New York.
108. Haemochromatosis Society (2006) Haemochromatosis. An iron overload disorder. http://www.ghsoc.org/pates/print.html (accessed 2 May 2008).
109. Haffner, S.M., Lehto, S., Ronnemaa, T., Pyorala, K. and Laakso, M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New England Journal of Medicine, 339, 229-34.
110. Hand, H. (2000) The development of diabetic ketoacidosis. Nursing Standard, 15, 47-55.
111. Happich, M., Landfraf, R., Piehlmeier, W., Falkenstein, P. and Stamentis, S. (2008) The economic burden of nephropathy in diabetic patients in Germany 2002. Diabetes Research and Clinical Practice, 80, 34-9.
112. Haslam, D.W. and James, W.P.T. (2005) Obesity. The Lancet, 366, 1197-209.
113. Heart Protection Study Collaborative Group. (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. The Lancet, 360, 7-22.
114. Henriksen, O.M., Prahl, J.B., Røder, M.E. and Svendsen, O.L. (2006) Treatment of diabetic ketoacidosis in adults in Denmark: a national survey. Diabetes Research and Clinical Practice, 77, 113-19.
115. Hermann, R., Knip, M., Veijola, R., et al. (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia, 46, 420-25.
116. Herrero, J.I., Quiroga, J., Sangro, B., et al. (2003) Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus. Transplantation Proceedings, 35, 1877-99.
117. Hettiarachchi, K.D., Zimmet, P.Z. and Myers, M.A. (2004) Transplacental exposure to bafilomycin disrupts pancreatic islet organogenesis and accelerates diabetes onset in NOD mice. Journal of Autoimmunity, 22, 287-96.
118. Hickman, I.J., Russell, A.J., Prins, J.B. and Macdonald, G.A. (2008) Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease? Diabetes Research and Clinical Practice, 80, e10-e12.
119. Hill, A. (2002) Continuous intravenous insulin infusion in patients with diabetes after cardiac surgery. Clinical Nurse Specialist, 16, 93-5.
120. Hirose, A., Ono, M., Saibara, T., et al. (2007) Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology, 45, 1375-81.
121. Hoek, J.B. and Pastorino, J.G. (2002) Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol, 27, 63-9.
122. Hovind, P., Tarnow, L., Rossing, P., Jensen, B.R., Graae, M., Torp, I., et al. (2004) Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. British Medical Journal, 328, 1105-8.
123. Humphries, C. (2002) The Hugely Better Calorie Counter Essentials. Foulsham, Berkshire.
124. IDF (2005) The International Diabetes Federation (IDF) consensus worldwide definition of the metabolic syndrome. April 14, 2005. http://www.idf.org/webdata/docs/Metac_ syndrome_def.pdf (accessed 22 January 2008).
125. IDF (2007) The International Diabetes Federation (IDF) recommends tighter control of blood glucose levels after meals in people with diabetes. Press release. http://www.idf. org/home/index.cfm?unode=BE8B67AD-1C8B-405C-A327-CB0B40272 (accessed 28 November 2007).
126. Ihnat, M.A., Thorpe, J.E. and Ceriello, A. (2007) Hypothesis: the 'metabolic memory', the new challenge of diabetes. Diabetic Medicine, 24, 582-6.
127. Ilag, L.L., Kronick, S., Ernst, R.D., et al. (2003) Impact of a critical pathway on inpatient management of diabetic ketoacidosis. Diabetes Research and Clinical Practice, 62, 1, 23-32.
128. JBS (2005) Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart, 91, (Suppl. 5), v1-v52.
129. Jellish, W.S., Kartha, V., Fluder, E. and Slogoff, S. (2005) Effects of metoclopramide on gastric fluid volumes in diabetic patients who have fasted before elective surgery. Anaesthesiology, 102, 904-9.
130. Jerreat, L. (2003) Diabetes for Nurses. John Wiley, London.
131. Jones, D.B. and Crosby, I. (1996) Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia, 39,1318-24.
132. Kaila, B., Dean, H.J., Schroeder, M. and Taback, S.P. (2003) HLA, day care attendance and socio-economic status in young patients with type 1 diabetes. Diabetic Medicine, 20, 777-80.
133. Karci, A., Tasdogen, A., Erkin, Y., Akta, G. and Elar, Z. (2004) The analgesic effect of morphine on postoperative pain in diabetic patients. Acta Anaesthesiologica Scandinavica, 48, 619-24.
134. Katzung, B.G. (1998) Basic and Clinical Pharmacology, 7th edn. Appleton and Lange, Connecticut.
135. Kershaw, E.E. and Flier, J.S. (2004) Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology Metabolism, 84, 2548-56.
136. Kersten, J.R., Warltier, D.C. and Pagel, P.S. (2005) Aggressive control of intraoperative blood glucose concentration; editorial view. Anaesthesiology, 103, 677-8.
137. Kettyle, W.M. and Arky, R.A. (1998) Endocrine Pathophysiology. Lippincott-Raven, New York.
138. Khaodhiar, L., Dinh, T., Schomacker, K., et al. (2007) The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care, 30, 903-10.
139. Kirby, M.G. (2006) NICE and hypertension-the judge's decision is final! The British Journal of Diabetes and Vascular Disease, 6, 177-9.
140. Kitabchi, A.E. and Wall, B.M. (1999) Management of diabetic ketoacidosis. American Family Physician, 60, 455-64.
141. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al. (2002) Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
142. Kumar, R. and Winocour, P.H. (2005) Dual blockade of the renin angiotensin system in diabetes-rationale and risks. The British Journal of Diabetes and Vascular Disease, 5, 266-71.
143. Kravitz, S.R., McGuire, J.B. and Sharma, S. (2007) The treatment of diabetic foot ulcers: reviewing the literature and a surgical algorithm. Skin and Wound, 20, 227-37.
144. Levetan, C.S., Passaro, M.D., Jablonski, K.A. and Ratner, R.E. (1999) Effect of physician speciality on outcomes in DKA. Diabetes Care, 22, 1790-5.
145. Levin, A., Thompson, C., Ethier, J., et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in haemoglobin. American Journal of Kidney Diseases, 34, 125-34.
146. Levy, D. (2006) Practical Diabetes, 2nd edn. Altman, Hertfordshire.
147. Li, Z., Yang, S., Lin, H., et al. (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve NAFLD. Hepatology, 37, 343-50.
148. Lieber, C.S., Leo, M.A., Mak, K.M., et al. (2004) Model of nonalcoholic steatohepatitis. American Journal of Clinical Nutrition, 79, 502-9.
149. Lilly, L.S. (2006) Pathophysiology of Heart Disease. A Collaborative Project of Medical Students and Faculty (4th edn). Lippincott Williams and Wilkins, London.
150. Lunt, H. and Brown, J.L.J. (1996) Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle. Diabetic Medicine, 13, 525-30.
151. Maggio, C.A. and Pi-Sunyer, F.X. (1997) The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care, 20, 1744-66.
152. Malmberg, K.A., Ryden, L., Efendic, S., et al. on behalf of the DIGAMI Study Group (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infraction in patients with diabetes. British Medical Journal, 314, 1512-15.
153. Malmberg, K.A., Ryden, L., Wedel, H., et al. for the DIGAMI 2 Investigators (2005) Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on morbidity and mortality. European Heart Journal, 26, 650-61.
154. Marchetti, P. (2005) New-onset diabetes after liver transplantation: from pathogenesis to management. Liver Transplantation, 11, 612-20.
155. Marieb, E.N. (2001) Human Anatomy and Physiology, 5th edn. Addison Wesley Longman, London.
156. Marks, J.B. (2003) Perioperative management of diabetes. American Family Physician, 67, 93-100.
157. Marshall, S.M. and Flyvbjerg, A. (2006) Prevention and early detection of vascular complications of diabetes. British Medical Journal, 333, 475-80.
158. Martini, F. (2006) Fundamentals of Anatomy and Physiology, 7th edn. Benjamin-Cummings, San Francisco.
159. Martini, F.H. and Karleskint, G. (1998) Foundations of Anatomy and Physiology. Prentice Hall, Upper Saddle River, NJ.
160. Matfin, G. (2007) Challenges in developing therapies for the metabolic syndrome. The British Journal of Diabetes and Vascular Disease, 7, 152-6.
161. McAvoy, N., Ferguson, J.W., Campbell, I.W. and Hayes, P.C. (2006) Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment. The British Journal of Diabetes and Vascular Disease, 6, 251-60.
162. McClain, D.A., Abraham, D., Rogers, J., et al. (2006) High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia, 49, 1661-9.
163. McCoubrey, A.S. (2007) The use of mechanical bowel preparation in elective colorectal surgery. Ulster Medical Journal, 76, 127-30.
164. McNeely, M.J., Boyko, E.J., Ahroni, J.H., Reiber, G., Smith, D.G. and Pecoraro, R.E. (1995) The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care, 18, 216-19.
165. Mende, C. (2006) Improving antihypertensive therapy in patients with diabetic nephropathy. Southern Medical Journal, 99, 150-7.
166. Menser, M.A., Forrest, J.M. and Bransby, R.D. (1978) Rubella infection and diabetes mellitus. The Lancet, 1, 57-60.
167. Mitrakou, A., Ryan, C., Veneman, T., et al. (1991) Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. American Journal of Physiology Endocrinology and Metabolism, 260, E67-E74.
168. Mogensen, C.E. (2003) Microalbuminuria and hypertension with a focus on type 1 and type 2 diabetes. Journal of International Medicine, 254, 45-66.
169. Mokdad, A.H., Ford, E.S. and Bowman, B.A. (2000) Diabetes trends in the U.S 1990-1998. Diabetes Care, 23, 1278-83.
170. Montgomery, M.P., Kamel, F., Saldana, T.M., Alvanja, M.C.R. and Sandler, D.P. (2008) Incident diabetes and pesticide exposure among licensed pesticide applicators: agricultural health study, 1993-2003. American Journal of Epidemiology, 67, 1235-46.
171. Mosby's (2002) Medical, Nursing and Allied Health Dictionary, 6th edn. Mosby, London.
172. Najarian, J., Swavely, D., Wilson, E. et al. (2005) Improving outcomes for diabetic patients undergoing vascular surgery. Diabetes Spectrum, 18, 53-60.
173. Nakamura, T., Ushiyama, C., Suzuki, S., et al. (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrology Dialysis Transplantation, 15, 1379-83.
174. Nathan, D.M., Buse, J.B., Davidson, M.B., et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia, 49, 1711-21.
175. National Diabetes Support Team (2008) Partners in care: a guide to implementing a care planning approach to diabetes care. National Diabetes Support Team, reference NDST062. http://www.diabetes.nhs.uk/news-1/Partners%20in%20Care.pdf (accessed 29 October 2008).
176. National Heart Lung and Blood Institute (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The Evidence Report. National Institutes of Health, Bethesda, Maryland.
177. National Kidney Foundation (2004) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Disease, 43 (Suppl. 1), S1-290.
178. Neligan, P.J. and Fleisher. L.A. (2006) Obesity and diabetes. Evidence of increased perioperative risk? Anaesthesiology, 104, 398-9.
179. NICE (2003) Guidance on the use of patient-education models for diabetes. Technology Appraisal Guidance 60. National Institute for Health and Clinical Excellence, London. http://www.nice.org.uk/nicemedia (accessed 2 July 2008).
180. NICE (2006) Inhaled insulin for the treatment of diabetes (types 1 and 2). Technology Appraisal Guidance 113. National Institute for Health and Clinical Excellence, London.
181. NICE (2008) Type 2 diabetes. The management of type 2 diabetes. Clinical Guideline 66. National Institute for Health and Clinical Excellence, London. http://www.nice.org. uk/guidance/index.jsp?action=downloadando=40754 (accessed 13 October 2008).
182. Nissen, S.E. and Wolski, K. (2007) Effect of Rosiglitazone on risk of myocardial infarction and death from cardiovascular disease. The New England Journal of Medicine, 356, 2457-71.
183. Norris, J.M. and Scott, F.W. (1996) A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role? Epidemiology, 7, 87-92.
184. Norris, S.L., Engelgau, M.M. and Venkat Narayan, K.M. (2001) Review: self management training in type 2 diabetes mellitus is effective in the short term. American College of Physicians Journal Club, Sept/Oct, p. 45.
185. Norris, S.L., Lau, J., Smith, S.J., Schmid, C.H. and Engelgau, M.M. (2002) Selfmanagement education for adults with type 2 diabetes: a meta-analysis of the effect on glycaemic control. Diabetes Care, 25, 1159-71.
186. Norris, S., Zhang, X., Avenell, A., et al. (2004) Long-term effectiveness of lifestyle and behavioural weight loss interventions in adults with type 2 diabetes: a meta-analysis. The American Journal of Medicine, 117, 762-74.
187. Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK. (2003) The implementation of nutritional advice for people with diabetes. Diabetic Medicine, 20, 786-807.
188. Olveira-Fuster, G., Olvera-Marquez, P., Carral-Sanlaureano, F., Gonzalez-Romero. S., Aguilar-Diosdado. M. and Soriguer-Escofet, F. (2004) Excess hospitalizations, hospital days, and inpatient costs among people with diabetes in Andalusia, Spain. Diabetes Care, 27, 1904-9.
189. Ouattara, A., Lecomte, P., Le Manach, Y., et al. (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anaesthesiology, 103, 687-94.
190. Page, S.R. and Hall, G.M. (1999) Diabetes Emergency and Hospital Management. BMJ Books, London.
191. Picardi, A., D'Avola, D., Gentilucci, U.V., et al. (2006) Diabetes in chronic liver disease: from old concepts to new evidence. Diabetes Metabolism Research and Reviews, 22, 274-83.
192. Pittas, A.G., Siegel, R.D. and Lau, J. (2004) Insulin therapy for critically ill hospitalized patients. A meta-analysis of randomised controlled trials. Archives of Internal Medicine, 164, 2005-11.
193. Plodkowski, R.A. and Edelman, S.V. (2001) Pre-surgical evaluation of diabetic patients. Clinical Diabetes, 19, 92-5.
194. Pozzilli, P. and Mario, U.D. (2001) Autoimmune diabetes not requiring insulin at diagnosis (Latent Autoimmune Diabetes of the Adult). Diabetes Care, 24, 1460-7.
195. Quality Outcomes Framework (2006/2007) The Quality Outcomes Framework. http://www. ic.nhs.uk/our-services/improving-patient-care/the-quality-and-outcomes-frameworkqof-2006-07 (accessed 15 July 2008).
196. Reichstein, L., Labrenz, S., Ziegler, D. and Martin, S. (2005) Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia, 48, 824-8.
197. Reilly, J.J. (2004) Prevention of obesity in children. Obesity in Practice, 6, 6-8.
198. Rennke, H.G. and Denker, B.M. (2007) Renal Pathophysiology: The Essentials, 2nd edn. Lippincott, Williams and Wilkins, London.
199. Richardson, T., Weiss, M., Thomas, P. and Kerr, D. (2005) Day after the night before. Diabetes Care, 28, 1801-2.
200. Rimm, E.B., Chan, J., Stampter, M.J., Colditz, G.A. and Willett, W.C. (1995) Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. British Medical Journal, 310, 555-9.
201. Rincon, J., Krook, A., Galuska, D., Walberg-Henriksson, H. and Sierath, J.R. (1999) Altered skeletal muscle glucose transport and blood lipids in habitual cigarette smokers. Clinical Physiology, 19, 135-42.
202. Rodacki, M., Pereira, J.R.D., de Oliveira, A.M.N., et al. (2007) Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Research and Clinical Practice, 78, 259-62.
203. Rorsman, P. (2005) Insulin secretion: function and therapy of pancreatic beta-cells in diabetes. The British Journal of Diabetes and Vascular Disease, 5, 187-91.
204. Sampson, M.J., Crowle, T., Dhatariaya, K., et al. (2006) Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service. Diabetic Medicine, 23, 1008-15.
205. Sato, T., Inagaki, A., Uchida, K., et al. (2003) Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A based therapy. Transplantation, 76, 1320-6.
206. Savage, M.W. and Kilvert, A. (2006) ABCD guidelines for the management of hyperglycaemic emergencies in adults. Practical Diabetes International, 23, 227-31.
207. Sawaki, H., Terasaki, J., Fujita, A., et al. (2008) A renoprotective effect of low dose losartan in patients with type 2 diabetes. Diabetes Research and Clinical Practice, 79, 86-90.
208. Schwarze, C.P. and Dunger, D.B. (2005) Management of early diabetic nephropathy in adolescents with type 1 diabetes mellitus. Practical Diabetes International, 22, 65-9.
209. Sharma, A., Kumar, S., Sharma, N., Jain, S. and Varma, S. (2007) Bilateral parietal lobe hemorrhage in a patient with diabetic ketoacidosis. Diabetes Research and Clinical Practice, 75, 379-80.
210. Shepherd, P.R. and Kahn, B.B. (1999) Glucose transporters and insulin action. New England Journal of Medicine, 341, 248-57.
211. Smithies, O. (2003) Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. The Proceedings of the National Academy of Sciences Online USA, 100, 4180-213.
212. Song, S.H. and Hardisty, C.A. (2007) Cardiovascular risk profile of early and later onset type 2 diabetes. Practical Diabetes International, 24, 20-4.
213. Soule, J.L., Olyaei, A.J., Boslaugh, T., et al. (2005) Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients. American Journal of Surgery, 189, 552-7.
214. Stehouwer, C.D.A., Nauta, J.J.P., Zeldenrust, G.C., et al. (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. The Lancet, 340, 319-23.
215. Stene, L.C., Ulriksen, J., Magnus, P. and Joner, G. (2000) Use of cod liver oil during pregnancy associated with lower risk of Type 1 diabetes in the offspring. Diabetologia, 43, 1093-8.
216. Stratton, I.M., Adler, A.I., Neil, H.A.W., et al. on behalf of the UK Prospective Diabetes Study Centre (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal, 321, 405-12.
217. Tamas, G., Tabak, A.G., Vargha, P. and Kerenyi, Z. (1996) Effect of menstrual cycle on insulin demand in IDDM women. Diabetologia, 39 (Suppl. 1):A52 (Abstract 188).
218. Targher, G., Bertolini, L., Poli, F., et al. (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes, 54, 3541-6.
219. Tavill, A.S. (2001) Diagnosis and management of haemochromatosis. Hepatology, 33, 1321-8.
220. Tesfaye, S. and Kempler, P. (2005) Painful diabetic neuropathy. Diabetologia, 48, 805-7.
221. The Diabetes Information Jigsaw (2006) http://www.abpi.org.uk/%2Fpublications% 2Fpdfs%2Fdiabetes_jigsaw.pdf (accessed 6 June 2008).
222. Thomson, F.J., Masson, E.A., Leeming, J.T. and Boulton, A.J.M. (1991) Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age and Ageing, 20, 404-6.
223. Toeller, M., Buyken, A., Heitkamp, G., et al. and the EURODIAB IDDM Complications Study Group (1997) Protein intake and urinary excretion rates in the EURODIAB IDDM Complications Study. Diabetologia, 40, 1219-26.
224. UK Prospective Diabetes Study. (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). British Medical Journal; 317, 703-13.
225. Umpierrez, G.E., Cuervo, R., Karabell, A., Latif, K., Freire, A.X. and Kitabchi, A.E. (2004) Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care, 27, 1873-8.
226. Vaarala, O., Knip, M., Paronen, J., et al. (1999) Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes, 48, 1389-94.
227. Valerkou, S. (2006) Structured education for people with type 1 diabetes. Diabetes Update, Winter, 38-40.
228. Van den Berghe, G. (2005) Insulin vs. strict blood glucose control to achieve a survival benefit after AMI? European Heart Journal, 26, 639-41.
229. Van den Berghe, G., Wouters, P., Weekers, F., et al. (2001) Intensive insulin therapy in critically ill patients. New England Journal of Medicine, 345, 1359-67.
230. Van de Wiel, A. (2004) Diabetes mellitus and alcohol. Diabetes Metabolism Research and Reviews, 20, 263-7.
231. Vora, J. and Weston, C. (2006) BENEDICT: primary prevention of microalbuminuria in hypertensive type 2 diabetics. The British Journal of Diabetes and Vascular Disease, 6, 84-6.
232. Wadden, T.A., Berkowitz, R.I., Womble, L.G., et al. (2005) Randomised trial of lifestyle modification and pharmacotherapy for obesity. New England Journal of Medicine, 353, 2111-20.
233. Walker, E.F. (1999) Management of diabetes and hyperglycaemia during myocardial infarction: review of the literature. Intensive and Critical Care Nursing, 15, 259-65.
234. Wallace, T.M., Meston, N.M., Gardner, S.G. and Matthews, D.R. (2001) The hospital and home use of a 30 second hand-held blood ketone meter: guidelines for clinical practice. Diabetic Medicine, 18, 640-45.
235. Wang, C.S., Wang, S.T., Yao, W.J., Chang, T.T. and Chou, P. (2007) Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. American Journal of Epidemiology, 166, 196-203.
236. WHO (1980) WHO Expert Committee on Diabetes Mellitus. Second Report. Technical Report Series 646. World Health Organization, Geneva.
237. WHO (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Organization, Geneva. http://www.who.int/diabetes/publications/ Definition%20and%20diagnosis%20of%20diabetes_new.pdf (accessed 15 March 2007).
238. WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. World Health Organization/ International Diabetes Federation. http://www.who.int/diabetes/publications (accessed 5 May 2008).
239. Wiernsperger, N.F. (2007) 50 years later: is metformin a vascular drug with antidiabetic properties? The British Journal of Diabetes and Vascular Disease, 7, 204-10.
240. Wikipedia (2007) Insulin analog. http://en.wikipedia.org/wik/insulin_analog (accessed 30 June 2007).
241. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates of the year 2000 and projections for 2030. Diabetes Care, 27, 1047-53.
242. Will, J.C., Galuska, A., Ford, E.S., Mokdad, A., Calle, E.E. (2001) Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. International Journal of Epidemiology, 30, 540-6.
243. Williams, B., Poulter, N.R. and Brown, M.J. (2004) Guidelines for management of hypertension: report of the fourth working party of the British Hypertensive Society. Journal of Human Hypertension, 18, 139-85.
244. Williams, G. and Pickup, J.C. (2004) Handbook of Diabetes, 3rd edn. Blackwell Publishing, Oxford.
245. Woerle, H.J., Neumann, C., Zschau, S., et al. (2006) Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Research and Clinical Practice, 77, 280-5.
246. Wolf, G., Chen, S. and Ziyadeh, F.N. (2005) From the periphery of the glomerular capillary wall to the centre of disease. Diabetes, 54, 1626-34.
247. Yunianingtias, D. and Volker, D. (2006) Nutritional aspects of non-alcoholic steatohepatitis treatment. Nutrition and Dietetics, 63, 79-90.
248. Zammitt, N.N. and Frier, B.M. (2005) Hypoglycaemia in Type 2 diabetes. Diabetes Care, 28, 2948-61.
249. Zimmet, P.Z., Tuomi, T., Mackay, R., et al. (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Medicine, 11, 299-303.